Deep, qualified subsequent-technology sequencing has exposed that subclonal mutations (i.e., All those present in only a portion of tumor cells) may be detected for all driver genes and so are associated with quick disease development and weak end result.eleven–thirteen This is particularly appropriate for TP53 mutations specified The truth that, https://marieg321per6.blogthisbiz.com/profile